Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer
PaperCitations, authors & open-access status
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 138 citations, 2023 year and closed oa status.
138
Citations
2023
Year
closed
OA Status